Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 203268-77-3 | MDL No. : | MFCD10690515 |
Formula : | C9H5N3OS | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | WGDXWQZBXRKGBU-UHFFFAOYSA-N |
M.W : | 203.22 | Pubchem ID : | 10104332 |
Synonyms : |
|
Num. heavy atoms : | 14 |
Num. arom. heavy atoms : | 11 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 4.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 51.7 |
TPSA : | 101.51 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | Yes |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.39 cm/s |
Log Po/w (iLOGP) : | 2.06 |
Log Po/w (XLOGP3) : | 1.62 |
Log Po/w (WLOGP) : | 1.9 |
Log Po/w (MLOGP) : | 1.0 |
Log Po/w (SILICOS-IT) : | 2.13 |
Consensus Log Po/w : | 1.74 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.64 |
Solubility : | 0.47 mg/ml ; 0.00231 mol/l |
Class : | Soluble |
Log S (Ali) : | -3.36 |
Solubility : | 0.0879 mg/ml ; 0.000433 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.59 |
Solubility : | 0.0527 mg/ml ; 0.000259 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.25 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With hydrogenchloride In water at 0 - 5℃; | General procedure: Compounds 6a-t were synthesized from substituted benzoic acid via six steps according to the literature method as described.1,2 Various substituted benzoic acids 1a-t were treated with SOCl2 to give compounds 2a-t, which were reacted with CH3OH and EtN3 in CH2Cl2 at 0 to afford compounds 3a-t. Compounds 4a-t were prepared by the reaction of compounds 3a-t, hydrazine hydrate in CH3OH under reflux condition about 5h. Subsequently, compounds 5a-t were obtained by reaction of compounds 4a-t with CS2 and KOH in CH3OH. Compounds 6a-t were obtained by the cyclization reaction of compounds 5a-t in the presence of HCl at 0-5°C. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: potassium carbonate / acetonitrile / 8 h / 20 °C 2: potassium carbonate; potassium iodide / acetonitrile / 80 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate In acetonitrile at 20℃; for 8h; | Synthesis of 2-[(3-bromopropyl)thio]-5-phenyl-1,3,4-oxadiazole (7a) General procedure: A mixture of 5-phenyl-1,3,4-oxadiazole-2-thiol (6a) (534 mg, 3 mmol) and 1,3-dibromoprop- ane (600 mg, 3 mmol) were dissolved in CH3CN (10 mL). Then K2CO3 (1.38 g, 10 mmol) was added. The reaction mixture was stirred at room temperature for 8 h. Then the reaction mixture was filtered and extracted with DCM. The organic layers were washed with water and dried over anhydrous NaSO4, filtered, and concentrated in vacuum. The residue was purified by silica gel column chromatography (DCM/MeOH, 30:1 v/v) to afford 1e (538 mg, 60%) as a colorless gum. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 5 steps 1: thionyl chloride / 5 h / Reflux 2: triethylamine / dichloromethane / 0 °C 3: hydrazine hydrate / methanol / 5 h / Reflux 4: potassium hydroxide / methanol / 20 °C / Reflux 5: hydrogenchloride / water / 0 - 5 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 4 steps 1: triethylamine / dichloromethane / 0 °C 2: hydrazine hydrate / methanol / 5 h / Reflux 3: potassium hydroxide / methanol / 20 °C / Reflux 4: hydrogenchloride / water / 0 - 5 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
Multi-step reaction with 2 steps 1: potassium hydroxide / methanol / 20 °C / Reflux 2: hydrogenchloride / water / 0 - 5 °C |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
With potassium carbonate In ethanol | 1.1 A, IV-1 synthesis of 2 . 03g (10mmol) compound II-1,3.70g (10mmol) compound III and 4.15g (30mmol) solid potassium carbonate in 20 ml ethanol and stirring overnight. Pouring the reaction mixture into 200 ml ice water, stirring, concentrated hydrochloric acid for adjusting pH=4,50 ml × 3 of dichloromethane extraction, combined with the phase, salt water washing, dry anhydrous sodium sulfate, the solvent evaporate the evaporimeter, the obtained residue is purified by column chromatography, get the pure product IV-1, white solid, MS, m/z=515 ([M+Na] +). |
[ 66147-19-1 ]
5-(m-Tolyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.95
[ 108413-54-3 ]
5-(3,5-Dimethylphenyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.95
[ 32058-82-5 ]
5-(4-Aminophenyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.88
[ 2503-66-4 ]
5-(o-Tolyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.88
[ 306936-90-3 ]
5-(4-(tert-Butyl)phenyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.85
[ 1016521-87-1 ]
3-(5-Amino-1,3,4-oxadiazol-2-yl)benzonitrile
Similarity: 0.72
[ 66147-19-1 ]
5-(m-Tolyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.95
[ 108413-54-3 ]
5-(3,5-Dimethylphenyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.95
[ 32058-82-5 ]
5-(4-Aminophenyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.88
[ 2503-66-4 ]
5-(o-Tolyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.88
[ 306936-90-3 ]
5-(4-(tert-Butyl)phenyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.85
[ 66147-19-1 ]
5-(m-Tolyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.95
[ 108413-54-3 ]
5-(3,5-Dimethylphenyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.95
[ 32058-82-5 ]
5-(4-Aminophenyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.88
[ 2503-66-4 ]
5-(o-Tolyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.88
[ 306936-90-3 ]
5-(4-(tert-Butyl)phenyl)-1,3,4-oxadiazole-2-thiol
Similarity: 0.85